Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Long-Term Deferred Tax (2024 - 2025)

Inspire Medical Systems (INSP) has disclosed Long-Term Deferred Tax for 2 consecutive years, with $88.7 million as the latest value for Q4 2025.

  • Quarterly Long-Term Deferred Tax rose 681953.85% to $88.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $88.7 million through Dec 2025, up 681953.85% year-over-year, with the annual reading at $88.7 million for FY2025, 681953.85% up from the prior year.
  • Long-Term Deferred Tax hit $88.7 million in Q4 2025 for Inspire Medical Systems, up from $13000.0 in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $88.7 million in Q4 2025 to a low of $13000.0 in Q4 2024.